Nurix Therapeutics, Inc. · NASDAQ:NRIX
FMR LLC's stake in Nurix Therapeutics, Inc. fell to 4.20% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 5, 2026
FMR LLC's stake in Nurix Therapeutics, Inc. fell to 4.20%, 4,350,596 shares, as a passive investor on Sep 30, 2026. Filed Nov 5, 2026 (Schedule 13G/A).
- Stake
- 4.20%
- Shares
- 4,350,596
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 4.20% | 4,350,596 |
| Abigail P. Johnson | 4.20% | 4,350,596 |
Source
Download original · View original at SEC
Related
- Nurix Therapeutics, Inc.
- FMR LLC
- Nurix Therapeutics, Inc. shareholders
- Schedule 13G · FMR LLC · May 6, 2026
- Schedule 13G/A · FMR LLC · Nov 7, 2025
- Schedule 13G/A · FMR LLC · Nov 5, 2025
- Schedule 13G/A · FMR LLC · May 12, 2025
- Schedule 13G/A · Rubric Capital Management LP · Nov 16, 2026
- Schedule 13G/A · Deep Track Capital, LP · Nov 16, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Nov 16, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Nov 16, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Nov 16, 2026